ATI Physical Therapy (ATIP) Stock Forecast, Price Target & Predictions
ATIP Stock Forecast
ATI Physical Therapy stock forecast is as follows: an average price target of $103.75 (represents a 1914.56% upside from ATIP’s last price of $5.15) and a rating consensus of 'Hold', based on 1 wall street analysts offering a 1-year stock forecast.
ATIP Price Target
ATIP Analyst Ratings
ATI Physical Therapy Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Nov 16, 2022 | - | Deutsche Bank | $32.50 | $27.51 | 18.16% | 531.07% |
Jan 14, 2022 | Jason Cassorla | Citigroup | $175.00 | $187.50 | -6.67% | 3298.06% |
ATI Physical Therapy Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $5.15 | $5.15 | $5.15 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Nov 16, 2022 | Deutsche Bank | Hold | Hold | Hold |
ATI Physical Therapy Financial Forecast
ATI Physical Therapy Revenue Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | $166.15M | - | $172.34M | $166.93M | $161.76M | $156.79M | $163.29M | $153.82M | $155.76M | $159.01M | $164.03M | $149.06M |
Avg Forecast | $204.20M | $197.00M | $199.40M | $194.00M | $193.67M | $185.13M | $190.00M | $181.90M | $177.39M | $168.89M | $170.07M | $161.47M | $162.68M | $164.16M | $168.19M | $155.23M | $156.48M | $159.63M | $175.91M | $161.90M |
High Forecast | $204.20M | $197.00M | $199.40M | $194.00M | $193.67M | $185.13M | $190.00M | $181.90M | $177.39M | $169.07M | $170.07M | $161.47M | $162.68M | $164.16M | $168.19M | $155.23M | $156.48M | $159.63M | $175.91M | $161.90M |
Low Forecast | $204.20M | $197.00M | $199.40M | $194.00M | $193.67M | $185.13M | $190.00M | $181.90M | $177.39M | $168.71M | $170.07M | $161.47M | $162.68M | $164.16M | $168.19M | $155.23M | $156.48M | $159.63M | $175.91M | $161.90M |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Surprise % | - | - | - | - | - | - | - | - | 0.94% | - | 1.01% | 1.03% | 0.99% | 0.96% | 0.97% | 0.99% | 1.00% | 1.00% | 0.93% | 0.92% |
ATI Physical Therapy EBITDA Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
EBITDA | - | - | - | - | - | - | - | - | $-3.34M | - | $8.36M | $9.82M | $13.95M | $9.00M | $-12.24M | $-1.20M | $20.63M | $-331.87M | $-428.02M | $12.43M |
Avg Forecast | $26.19M | $25.27M | $25.58M | $24.89M | $24.84M | $23.75M | $24.37M | $-232.47M | $22.76M | $21.66M | $21.82M | $-211.34M | $31.20M | $21.06M | $21.57M | $-192.13M | $20.07M | $20.48M | $-246.64M | $20.77M |
High Forecast | $26.19M | $25.27M | $25.58M | $24.89M | $24.84M | $23.75M | $24.37M | $-185.98M | $22.76M | $21.69M | $21.82M | $-169.07M | $37.44M | $21.06M | $21.57M | $-153.70M | $20.07M | $20.48M | $-197.32M | $20.77M |
Low Forecast | $26.19M | $25.27M | $25.58M | $24.89M | $24.84M | $23.75M | $24.37M | $-278.97M | $22.76M | $21.64M | $21.82M | $-253.61M | $24.96M | $21.06M | $21.57M | $-230.55M | $20.07M | $20.48M | $-295.97M | $20.77M |
Surprise % | - | - | - | - | - | - | - | - | -0.15% | - | 0.38% | -0.05% | 0.45% | 0.43% | -0.57% | 0.01% | 1.03% | -16.21% | 1.74% | 0.60% |
ATI Physical Therapy Net Income Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Net Income | - | - | - | - | - | - | - | - | $-5.62M | - | $-22.70M | $-25.21M | $-102.41M | $-116.69M | $-135.72M | $-138.22M | $8.74M | $-331.71M | $-448.69M | $-19.13M |
Avg Forecast | $-10.73M | $-13.21M | $-11.34M | $-13.86M | $-9.93M | $-13.39M | $-11.43M | $-245.47M | $-15.02M | $-21.82M | $-15.36M | $-223.15M | $6.30M | $-16.96M | $-12.27M | $-202.87M | $-15.29M | $-9.78M | $-246.78M | $-10.87M |
High Forecast | $-10.73M | $-13.21M | $-11.34M | $-13.86M | $-9.93M | $-13.39M | $-11.43M | $-196.38M | $-15.02M | $-21.82M | $-15.36M | $-178.52M | $7.56M | $-16.96M | $-12.27M | $-162.29M | $-15.29M | $-9.78M | $-197.42M | $-10.87M |
Low Forecast | $-10.73M | $-13.21M | $-11.34M | $-13.86M | $-9.93M | $-13.39M | $-11.43M | $-294.56M | $-15.02M | $-21.82M | $-15.36M | $-267.79M | $5.04M | $-16.96M | $-12.27M | $-243.44M | $-15.29M | $-9.78M | $-296.14M | $-10.87M |
Surprise % | - | - | - | - | - | - | - | - | 0.37% | - | 1.48% | 0.11% | -16.25% | 6.88% | 11.06% | 0.68% | -0.57% | 33.92% | 1.82% | 1.76% |
ATI Physical Therapy SG&A Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
SG&A | - | - | - | - | - | - | - | - | $26.48M | - | $36.57M | $30.59M | $27.63M | $25.26M | $31.81M | $30.02M | $29.90M | $30.80M | $26.39M | $24.73M |
Avg Forecast | $34.96M | $33.72M | $34.14M | $33.21M | $33.15M | $31.69M | $32.53M | $53.50M | $30.37M | $28.91M | $29.11M | $48.64M | $45.22M | $28.10M | $28.79M | $44.22M | $26.79M | $27.33M | $14.52M | $27.72M |
High Forecast | $34.96M | $33.72M | $34.14M | $33.21M | $33.15M | $31.69M | $32.53M | $64.20M | $30.37M | $28.94M | $29.11M | $58.37M | $54.26M | $28.10M | $28.79M | $53.06M | $26.79M | $27.33M | $17.42M | $27.72M |
Low Forecast | $34.96M | $33.72M | $34.14M | $33.21M | $33.15M | $31.69M | $32.53M | $42.80M | $30.37M | $28.88M | $29.11M | $38.91M | $36.18M | $28.10M | $28.79M | $35.37M | $26.79M | $27.33M | $11.61M | $27.72M |
Surprise % | - | - | - | - | - | - | - | - | 0.87% | - | 1.26% | 0.63% | 0.61% | 0.90% | 1.10% | 0.68% | 1.12% | 1.13% | 1.82% | 0.89% |
ATI Physical Therapy EPS Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
EPS | - | - | - | - | - | - | - | - | $-1.35 | - | $-5.51 | $-0.12 | $-0.52 | $-0.59 | $-0.69 | $-0.69 | $0.04 | $-1.65 | $-0.03 | $-0.10 |
Avg Forecast | $-2.47 | $-3.04 | $-2.61 | $-3.19 | $-2.29 | $-3.08 | $-2.63 | $-4.43 | $-3.46 | $-5.02 | $-3.53 | $-4.26 | $-3.82 | $-3.90 | $-2.82 | $-5.08 | $-3.52 | $-2.25 | $-0.09 | $-2.50 |
High Forecast | $-2.47 | $-3.04 | $-2.61 | $-3.19 | $-2.29 | $-3.08 | $-2.63 | $-4.43 | $-3.46 | $-5.02 | $-3.53 | $-4.26 | $-3.82 | $-3.90 | $-2.82 | $-5.08 | $-3.52 | $-2.25 | $-0.09 | $-2.50 |
Low Forecast | $-2.47 | $-3.04 | $-2.61 | $-3.19 | $-2.29 | $-3.08 | $-2.63 | $-4.43 | $-3.46 | $-5.02 | $-3.53 | $-4.26 | $-3.82 | $-3.90 | $-2.82 | $-5.08 | $-3.52 | $-2.25 | $-0.09 | $-2.50 |
Surprise % | - | - | - | - | - | - | - | - | 0.39% | - | 1.56% | 0.03% | 0.14% | 0.15% | 0.24% | 0.14% | -0.01% | 0.73% | 0.30% | 0.04% |
ATI Physical Therapy Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
TOI | Oncology Institute | $0.28 | $8.00 | 2757.14% | Buy |
ATIP | ATI Physical Therapy | $5.15 | $103.75 | 1914.56% | Hold |
ACHC | Acadia Healthcare Company | $42.33 | $82.33 | 94.50% | Buy |
SGRY | Surgery Partners | $29.22 | $44.33 | 51.71% | Buy |
AMED | Amedisys | $95.39 | $143.38 | 50.31% | Hold |
EHAB | Enhabit | $7.63 | $10.25 | 34.34% | Hold |
INNV | InnovAge | $5.90 | $6.80 | 15.25% | Hold |
SEM | Select Medical | $36.51 | $40.00 | 9.56% | Buy |
PNTG | Pennant Group | $32.38 | $34.67 | 7.07% | Buy |
UHS | Universal Health Services | $208.83 | $208.47 | -0.17% | Hold |
AIRS | AirSculpt | $6.69 | $6.67 | -0.30% | Hold |
EHC | Encompass Health | $100.23 | $97.00 | -3.22% | Buy |
ENSG | Ensign Group | $153.39 | $148.20 | -3.38% | Buy |
AVAH | Aveanna Healthcare | $4.51 | $4.10 | -9.09% | Buy |
ATIP Forecast FAQ
Is ATI Physical Therapy a good buy?
No, according to 1 Wall Street analysts, ATI Physical Therapy (ATIP) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of ATIP's total ratings.
What is ATIP's price target?
ATI Physical Therapy (ATIP) average price target is $103.75 with a range of $32.5 to $175, implying a 1914.56% from its last price of $5.15. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will ATI Physical Therapy stock go up soon?
According to Wall Street analysts' prediction for ATIP stock, the company can go up by 1914.56% (from the last price of $5.15 to the average price target of $103.75), up by 3298.06% based on the highest stock price target, and up by 531.07% based on the lowest stock price target.
Can ATI Physical Therapy stock reach $8?
ATIP's average twelve months analyst stock price target of $103.75 supports the claim that ATI Physical Therapy can reach $8 in the near future.
What are ATI Physical Therapy's analysts' financial forecasts?
ATI Physical Therapy's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $750.7M (high $750.7M, low $750.7M), average EBITDA is $-160M (high $-113M, low $-206M), average net income is $-280M (high $-231M, low $-329M), average SG&A $150.88M (high $161.58M, low $140.18M), and average EPS is $-12.43 (high $-12.43, low $-12.43). ATIP's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $794.6M (high $794.6M, low $794.6M), average EBITDA is $101.93M (high $101.93M, low $101.93M), average net income is $-49.153M (high $-49.153M, low $-49.153M), average SG&A $136.03M (high $136.03M, low $136.03M), and average EPS is $-11.31 (high $-11.31, low $-11.31).
Did the ATIP's actual financial results beat the analysts' financial forecasts?
Based on ATI Physical Therapy's last annual report (Dec 2023), the company's revenue was $636.1M, which missed the average analysts forecast of $677.82M by -6.16%. Apple's EBITDA was $-67.227M, missing the average prediction of $-145M by -53.67%. The company's net income was $-69.795M, missing the average estimation of $-275M by -74.65%. Apple's SG&A was $118.73M, missing the average forecast of $137.03M by -13.36%. Lastly, the company's EPS was $-16.89, beating the average prediction of $-16.271 by 3.80%. In terms of the last quarterly report (Dec 2023), ATI Physical Therapy's revenue was $166.14M, missing the average analysts' forecast of $177.39M by -6.34%. The company's EBITDA was $-3.337M, missing the average prediction of $22.76M by -114.66%. ATI Physical Therapy's net income was $-5.623M, missing the average estimation of $-15.015M by -62.55%. The company's SG&A was $26.48M, missing the average forecast of $30.37M by -12.82%. Lastly, the company's EPS was $-1.35, missing the average prediction of $-3.455 by -60.93%